Groundbreaking immunotherapy shows promise in type 1 diabetes

It may be feasible to retrainrsquo; the immune system to slow the progression of type one diabetes, according to results of a clinical trial published on the 9thnbsp; August in the journalnbsp; Science Translational Medicine. nbsp;

Leave a Reply

Your email address will not be published. Required fields are marked *